Healthcare Sector Stocks
The Healthcare sector has a total of 1048 stocks, with a combined market cap of $10.11 trillion, total revenue of $4.74 trillion and a weighted average PE ratio of 47.47.
Market Cap
10.11T
Revenue
4.74T
Profits
213.03B
PE Ratio
47.47
Profit Margin
4.49%
Dividend Yield
0.37%
1047 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.28T | 0.35% | 1,885,528 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 675.03B | -0.13% | 5,437,283 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 521.41B | 0.37% | 3,262,258 | 66.01B |
| 4 | MRK | Merck & Co., Inc. | 362.83B | -0.59% | 6,414,136 | 67.38B |
| 5 | UNH | UnitedHealth Group Incorporated | 361.04B | -0.54% | 4,141,623 | 450.06B |
| 6 | NVS | Novartis AG | 301.07B | -1.80% | 2,322,038 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 286.32B | -0.69% | 1,433,675 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 265.92B | -0.07% | 1,818,991 | 47.35B |
| 9 | AMGN | Amgen Inc. | 253.21B | 0.62% | 2,006,460 | 38.90B |
| 10 | GILD | Gilead Sciences, Inc. | 210.52B | -0.67% | 4,883,484 | 30.99B |
| 11 | ABT | Abbott Laboratories | 189.28B | -1.06% | 8,970,774 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 178.45B | 0.96% | 11,703,417 | 50.70B |
| 13 | PFE | Pfizer Inc. | 167.86B | 0.31% | 26,027,924 | 63.62B |
| 14 | DHR | Danaher Corporation | 165.55B | -0.34% | 3,228,144 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 155.83B | -0.11% | 1,752,705 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 138.69B | -0.16% | 1,024,245 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.59B | 0.18% | 6,429,773 | 50.03B |
| 18 | MCK | McKesson Corporation | 124.67B | -0.26% | 474,899 | 418.79B |
| 19 | MDT | Medtronic plc | 124.38B | 0.02% | 4,389,283 | 37.54B |
| 20 | SYK | Stryker Corporation | 121.36B | -1.70% | 3,215,564 | 26.30B |
| 21 | SNY | Sanofi | 115.13B | 0.41% | 2,436,150 | 57.89B |
| 22 | CVS | CVS Health Corporation | 114.54B | 0.57% | 11,082,127 | 418.16B |
| 23 | HCA | HCA Healthcare, Inc. | 105.71B | 0.32% | 1,201,350 | 78.70B |
| 24 | MRNA | Moderna, Inc. | 100.63B | -0.85% | 7,593,555 | 2.53B |
| 25 | GSK | GSK plc | 100.45B | -1.23% | 2,701,315 | 44.53B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 96.27B | 4.73% | 1,233,342 | 16.90B |
| 27 | ELV | Elevance Health, Inc. | 92.79B | -0.04% | 698,273 | 201.83B |
| 28 | CI | The Cigna Group | 79.43B | -0.55% | 1,471,669 | 286.32B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 68.20B | -0.43% | 1,963,966 | 29.86B |
| 30 | COR | Cencora, Inc. | 66.77B | 0.34% | 845,620 | 337.40B |
| 31 | BSX | Boston Scientific Corporation | 65.41B | 0.96% | 17,786,953 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 64.13B | 0.24% | 980,046 | 257.75B |
| 33 | EW | Edwards Lifesciences Corporation | 60.84B | 1.73% | 4,252,317 | 6.67B |
| 34 | ARGX | argenx SE | 60.74B | 0.62% | 246,242 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 58.43B | 0.90% | 1,637,591 | 19.46B |
| 36 | MDLN | Medline Inc. | 55.45B | 3.06% | 8,314,152 | 30.68B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 55.35B | 0.85% | 422,796 | 4.66B |
| 38 | HUM | Humana Inc. | 53.60B | 1.88% | 2,500,363 | 154.19B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 50.45B | 1.98% | 9,562,602 | 17.23B |
| 40 | A | Agilent Technologies, Inc. | 49.89B | -0.52% | 1,908,737 | 7.37B |
| 41 | VEEV | Veeva Systems Inc. | 49.34B | -0.26% | 1,042,951 | 3.46B |
| 42 | ONC | BeOne Medicines AG | 47.97B | -0.95% | 486,213 | 6.45B |
| 43 | NTRA | Natera, Inc. | 46.38B | 2.51% | 1,746,860 | 2.91B |
| 44 | WAT | Waters Corporation | 46.28B | -0.97% | 651,943 | 5.61B |
| 45 | IQV | IQVIA Holdings Inc. | 45.24B | -0.23% | 1,365,400 | 17.31B |
| 46 | RPRX | Royalty Pharma plc | 40.16B | 0.81% | 3,532,759 | 2.62B |
| 47 | HLN | Haleon plc | 39.62B | 0.44% | 21,451,692 | 14.80B |
| 48 | RVMD | Revolution Medicines, Inc. | 39.08B | -6.40% | 3,262,476 | 197.56M |
| 49 | BIIB | Biogen Inc. | 37.46B | 0.06% | 1,115,338 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 37.35B | -1.26% | 3,487,457 | 21.64B |
| 51 | CNC | Centene Corporation | 34.89B | 0.41% | 4,200,314 | 180.41B |
| 52 | MTD | Mettler-Toledo International Inc. | 34.79B | -0.14% | 100,697 | 4.20B |
| 53 | ALC | Alcon Inc. | 34.53B | -2.16% | 4,865,245 | 10.98B |
| 54 | RMD | ResMed Inc. | 33.55B | 1.89% | 944,331 | 5.73B |
| 55 | ZTS | Zoetis Inc. | 33.55B | 0.13% | 4,450,269 | 9.49B |
| 56 | GMAB | Genmab A/S | 33.45B | -0.37% | 3,918,631 | 4.30B |
| 57 | ILMN | Illumina, Inc. | 32.20B | -0.92% | 1,864,969 | 4.54B |
| 58 | ROIV | Roivant Sciences Ltd. | 30.32B | 1.60% | 7,982,651 | 41.08M |
| 59 | LH | Labcorp Holdings Inc. | 30.23B | 0.36% | 741,770 | 14.59B |
| 60 | DXCM | DexCom, Inc. | 29.96B | 0.53% | 3,231,068 | 5.10B |
| 61 | PHG | Koninklijke Philips N.V. | 29.43B | -0.69% | 1,773,697 | 20.16B |
| 62 | WST | West Pharmaceutical Services, Inc. | 28.76B | 0.08% | 331,515 | 3.40B |
| 63 | DGX | Quest Diagnostics Incorporated | 28.46B | 0.10% | 746,602 | 11.84B |
| 64 | INSM | Insmed Incorporated | 26.49B | 1.05% | 1,488,878 | 1.52B |
| 65 | UTHR | United Therapeutics Corporation | 25.37B | 1.20% | 369,289 | 3.19B |
| 66 | INCY | Incyte Corporation | 24.92B | 1.64% | 1,187,539 | 6.01B |
| 67 | STE | STERIS plc | 24.89B | -0.33% | 596,625 | 6.17B |
| 68 | VTRS | Viatris Inc. | 24.14B | 1.01% | 14,429,550 | 14.73B |
| 69 | THC | Tenet Healthcare Corporation | 23.32B | 0.93% | 686,179 | 22.15B |
| 70 | BNTX | BioNTech SE | 21.73B | 0.50% | 765,489 | 2.75B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.41B | 5.41% | 3,360,726 | 5.01B |
| 72 | GH | Guardant Health, Inc. | 20.94B | -0.37% | 1,519,226 | 1.28B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 20.34B | 0.14% | 1,296,361 | 8.57B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.59B | 0.03% | 134,529 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.67B | -0.53% | 1,173,560 | 2.94B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 17.65B | 3.12% | 1,144,356 | 3.70B |
| 77 | EXEL | Exelixis, Inc. | 17.25B | 0.17% | 2,230,011 | 2.50B |
| 78 | ASND | Ascendis Pharma A/S | 17.03B | 1.05% | 883,424 | 1.20B |
| 79 | CRL | Charles River Laboratories International, Inc. | 16.42B | -0.90% | 836,557 | 3.98B |
| 80 | JAZZ | Jazz Pharmaceuticals plc | 15.93B | 1.14% | 592,827 | 4.72B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 15.49B | 1.11% | 2,324,722 | 945.54M |
| 82 | BTSG | BrightSpring Health Services, Inc. | 15.13B | 0.18% | 2,115,444 | 15.25B |
| 83 | SOLV | Solventum Corporation | 15.04B | -1.62% | 728,321 | 8.16B |
| 84 | ICLR | ICON Public Limited Company | 14.96B | -2.41% | 647,165 | 8.23B |
| 85 | GKOS | Glaukos Corporation | 14.62B | 4.64% | 915,596 | 690.33M |
| 86 | TEM | Tempus AI, Inc. | 14.49B | -1.38% | 4,231,000 | 1.51B |
| 87 | EHC | Encompass Health Corporation | 13.96B | -0.19% | 685,019 | 6.34B |
| 88 | BAX | Baxter International Inc. | 13.63B | -0.30% | 3,826,031 | 11.61B |
| 89 | SMMT | Summit Therapeutics Inc. | 13.31B | -6.67% | 3,891,687 | - |
| 90 | ELAN | Elanco Animal Health Incorporated | 13.24B | -1.05% | 3,775,461 | 5.15B |
| 91 | SNN | Smith & Nephew plc | 12.84B | 0.39% | 1,177,563 | 6.30B |
| 92 | PEN | Penumbra, Inc. | 12.68B | 0.08% | 320,186 | 1.56B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 12.22B | -0.13% | 2,176,814 | 3.44B |
| 94 | ALGN | Align Technology, Inc. | 12.13B | -1.25% | 860,481 | 4.16B |
| 95 | COO | The Cooper Companies, Inc. | 11.97B | -1.01% | 1,679,223 | 4.24B |
| 96 | FMS | Fresenius Medical Care AG | 11.75B | -2.29% | 5,971,320 | 22.12B |
| 97 | HALO | Halozyme Therapeutics, Inc. | 11.59B | -1.26% | 2,504,458 | 1.80B |
| 98 | DVA | DaVita Inc. | 11.55B | 2.35% | 573,328 | 14.17B |
| 99 | KYMR | Kymera Therapeutics, Inc. | 11.51B | -1.32% | 551,602 | 102.24M |
| 100 | TECH | Bio-Techne Corporation | 11.44B | -0.03% | 2,602,372 | 1.23B |
| 101 | UHS | Universal Health Services, Inc. | 11.34B | 0.70% | 540,625 | 18.35B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 11.30B | 2.10% | 1,658,719 | 3.66B |
| 103 | RGEN | Repligen Corporation | 11.03B | -0.78% | 1,000,615 | 805.61M |
| 104 | MOH | Molina Healthcare, Inc. | 10.90B | 1.41% | 553,773 | 42.08B |
| 105 | PCVX | Vaxcyte, Inc. | 10.86B | 3.41% | 1,640,937 | - |
| 106 | ENSG | The Ensign Group, Inc. | 10.77B | 0.59% | 244,344 | 5.67B |
| 107 | AVTR | Avantor, Inc. | 10.66B | 1.03% | 5,536,837 | 6.64B |
| 108 | PODD | Insulet Corporation | 10.41B | 1.33% | 1,042,722 | 3.19B |
| 109 | QGEN | Qiagen N.V. | 10.39B | -0.42% | 2,372,347 | 2.12B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 10.38B | -0.12% | 212,183 | 2.59B |
| 111 | SYRE | Spyre Therapeutics, Inc. | 10.14B | 2.24% | 1,036,346 | - |
| 112 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.06B | 0.10% | 296,515 | 1.43B |
| 113 | GMED | Globus Medical, Inc. | 9.99B | 0.21% | 1,899,666 | 3.14B |
| 114 | OSCR | Oscar Health, Inc. | 9.97B | -4.06% | 3,709,019 | 17.47B |
| 115 | HNGE | Hinge Health, Inc. | 9.89B | -1.23% | 1,157,283 | 800.82M |
| 116 | HSIC | Henry Schein, Inc. | 9.77B | -0.36% | 1,005,474 | 13.73B |
| 117 | PRAX | Praxis Precision Medicines, Inc. | 9.68B | 2.55% | 758,746 | 7.46M |
| 118 | BRKR | Bruker Corporation | 9.53B | 0.27% | 2,470,759 | 3.51B |
| 119 | MTRI | Mentari Therapeutics, Inc. | 9.38B | 27.94% | 60,077 | - |
| 120 | TGTX | TG Therapeutics, Inc. | 9.21B | 2.33% | 2,055,107 | 897.76M |
| 121 | KRYS | Krystal Biotech, Inc. | 9.15B | 0.75% | 174,779 | 470.03M |
| 122 | ATR | AptarGroup, Inc. | 9.07B | -0.72% | 475,455 | 3.99B |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.80B | -1.03% | 332,589 | 551.69M |
| 124 | HQY | HealthEquity, Inc. | 8.52B | -0.49% | 581,384 | 1.36B |
| 125 | TXG | 10x Genomics, Inc. | 8.16B | -1.35% | 1,752,011 | 618.58M |
| 126 | CORT | Corcept Therapeutics Incorporated | 8.16B | 1.61% | 1,115,676 | 963.65M |
| 127 | CYTK | Cytokinetics, Incorporated | 8.15B | 4.18% | 2,811,699 | 113.29M |
| 128 | ABVX | ABIVAX Société Anonyme | 8.06B | 1.60% | 739,082 | 5.33M |
| 129 | ALKS | Alkermes plc | 8.05B | 3.06% | 1,031,712 | 1.75B |
| 130 | PACS | PACS Group, Inc. | 7.95B | 1.96% | 1,003,555 | 5.71B |
| 131 | AXSM | Axsome Therapeutics, Inc. | 7.85B | 5.87% | 1,072,492 | 865.27M |
| 132 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.78B | -1.57% | 734,103 | 280.75M |
| 133 | TWST | Twist Bioscience Corporation | 7.69B | -7.22% | 3,465,271 | 431.80M |
| 134 | IMVT | Immunovant, Inc. | 7.67B | 3.72% | 1,712,162 | - |
| 135 | GRFS | Grifols, S.A. | 7.63B | 0.91% | 724,575 | 8.63B |
| 136 | BLCO | Bausch + Lomb Corporation | 7.62B | -0.23% | 658,491 | 5.42B |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 7.56B | 1.54% | 2,470,526 | 3.20B |
| 138 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.52B | 0.78% | 581,147 | 945.96M |
| 139 | ORKA | Oruka Therapeutics, Inc. | 7.27B | -2.13% | 844,076 | - |
| 140 | CHE | Chemed Corporation | 7.14B | 1.13% | 189,322 | 2.66B |
| 141 | IBRX | ImmunityBio, Inc. | 7.10B | -1.19% | 11,967,527 | 182.57M |
| 142 | CAI | Caris Life Sciences, Inc. | 7.02B | 0.25% | 4,681,748 | 1.05B |
| 143 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.97B | 0.73% | 2,529,166 | 669.50M |
| 144 | KOD | Kodiak Sciences Inc. | 6.86B | 1.18% | 689,207 | - |
| 145 | LNTH | Lantheus Holdings, Inc. | 6.64B | -0.02% | 1,021,044 | 1.56B |
| 146 | MANE | Veradermics, Incorporated | 6.61B | 5.47% | 713,705 | - |
| 147 | CGON | CG Oncology, Inc. | 6.49B | -0.04% | 890,126 | 6.17M |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.34B | 0.85% | 126,777 | 253.83M |
| 149 | BLTE | Belite Bio, Inc | 6.28B | -0.37% | 260,048 | - |
| 150 | TFX | Teleflex Incorporated | 6.20B | 0.66% | 610,440 | 2.26B |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.18B | 0.20% | 528,387 | 670.78M |
| 152 | RDNT | RadNet, Inc. | 6.15B | 0.18% | 732,294 | 2.38B |
| 153 | SUPN | Supernus, Inc. | 6.12B | 2.43% | 3,068,615 | 1.37B |
| 154 | DOCS | Doximity, Inc. | 5.93B | 2.47% | 2,277,886 | 661.58M |
| 155 | ERAS | Erasca, Inc. | 5.88B | 8.53% | 13,795,698 | - |
| 156 | SRRK | Scholar Rock Holding Corporation | 5.69B | -2.92% | 1,488,038 | 570.00K |
| 157 | GRAL | GRAIL, Inc. | 5.65B | 0.72% | 494,423 | 166.60M |
| 158 | WAY | Waystar Holding Corp. | 5.55B | -1.57% | 1,669,335 | 1.26B |
| 159 | CON | Concentra Group Holdings Parent, Inc. | 5.50B | 1.83% | 626,253 | 2.34B |
| 160 | HAE | Haemonetics Corporation | 5.49B | -1.49% | 390,233 | 1.38B |
| 161 | LFST | LifeStance Health Group, Inc. | 5.46B | -1.30% | 12,040,434 | 1.68B |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.42B | 1.20% | 724,937 | 1.16B |
| 163 | MMSI | Merit Medical Systems, Inc. | 5.28B | 0.30% | 441,978 | 1.61B |
| 164 | BLLN | BillionToOne, Inc. | 5.27B | -1.58% | 837,012 | 436.87M |
| 165 | EWTX | Edgewise Therapeutics, Inc. | 5.21B | 2.24% | 1,343,118 | - |
| 166 | HTFL | HeartFlow, Inc. | 5.14B | 5.91% | 2,068,455 | 212.07M |
| 167 | MMED | MiniMed Group, Inc. | 5.13B | 5.13% | 5,553,695 | 3.22B |
| 168 | COGT | Cogent Biosciences, Inc. | 5.12B | -7.08% | 4,513,605 | - |
| 169 | DNTH | Dianthus Therapeutics, Inc. | 5.03B | 0.55% | 794,735 | 2.72M |
| 170 | LIVN | LivaNova PLC | 5.01B | -0.18% | 652,687 | 1.51B |
| 171 | TVTX | Travere Therapeutics, Inc. | 5.00B | 0.10% | 762,379 | 651.03M |
| 172 | LQDA | Liquidia Corporation | 4.97B | 7.41% | 3,873,923 | 621.87M |
| 173 | HIMS | Hims & Hers Health, Inc. | 4.88B | 8.78% | 23,730,930 | 2.87B |
| 174 | ADPT | Adaptive Biotechnologies Corporation | 4.85B | 1.98% | 2,645,238 | 298.01M |
| 175 | OPCH | Option Care Health, Inc. | 4.75B | 0.16% | 5,398,772 | 5.75B |
| 176 | DFTX | Definium Therapeutics, Inc. | 4.72B | -0.49% | 1,441,471 | - |
| 177 | IONS | Ionis Pharmaceuticals, Inc. | 4.72B | 0.50% | 6,552,104 | 960.09M |
| 178 | SHC | Sotera Health Company | 4.70B | 1.04% | 2,894,675 | 1.23B |
| 179 | ICUI | ICU Medical, Inc. | 4.46B | -2.11% | 299,197 | 2.18B |
| 180 | CRSP | CRISPR Therapeutics AG | 4.44B | 1.33% | 2,679,979 | 25.17M |
| 181 | TNGX | Tango Therapeutics, Inc. | 4.36B | 5.88% | 3,862,999 | 53.81M |
| 182 | RLAY | Relay Therapeutics, Inc. | 4.36B | -1.10% | 1,932,178 | 10.35M |
| 183 | ITGR | Integer Holdings Corporation | 4.31B | 0.05% | 313,568 | 1.83B |
| 184 | CDNA | CareDx, Inc. | 4.26B | 0.50% | 770,744 | 497.40M |
| 185 | PLSE | Pulse Biosciences, Inc. | 4.19B | 3.37% | 357,508 | 1.49M |
| 186 | XENE | Xenon Pharmaceuticals Inc. | 4.14B | 1.72% | 1,252,574 | 7.50M |
| 187 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.09B | 2.88% | 2,001,377 | -665.00K |
| 188 | NVST | Envista Holdings Corporation | 4.06B | -2.01% | 2,348,540 | 2.88B |
| 189 | IRON | Disc Medicine, Inc. | 3.97B | 2.88% | 669,013 | - |
| 190 | ABCL | AbCellera Biologics Inc. | 3.87B | -4.09% | 2,874,184 | 67.85M |
| 191 | STVN | Stevanato Group S.p.A. | 3.80B | 2.81% | 1,041,312 | 1.42B |
| 192 | LEGN | Legend Biotech Corporation | 3.79B | -4.26% | 4,417,172 | 1.36B |
| 193 | TARS | Tarsus Pharmaceuticals, Inc. | 3.78B | 3.97% | 749,306 | 682.20M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.77B | -0.02% | 781,455 | - |
| 195 | WRBY | Warby Parker Inc. | 3.75B | 0.84% | 5,026,884 | 934.66M |
| 196 | IOVA | Iovance Biotherapeutics, Inc. | 3.74B | 0.12% | 8,408,426 | 378.98M |
| 197 | PBLS | Parabilis Medicines, Inc. | 3.66B | -1.23% | 546,012 | 148.00K |
| 198 | OGN | Organon & Co. | 3.65B | - | 1,870,559 | 6.10B |
| 199 | VKTX | Viking Therapeutics, Inc. | 3.63B | -0.77% | 2,653,947 | - |
| 200 | ACHC | Acadia Healthcare Company, Inc. | 3.61B | 0.41% | 2,644,617 | 3.41B |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.59B | 3.61% | 2,490,612 | 508.68M |
| 202 | VRDN | Viridian Therapeutics, Inc. | 3.55B | 1.26% | 2,826,411 | 26.31M |
| 203 | AXGN | Axogen, Inc. | 3.50B | 15.21% | 4,455,379 | 266.93M |
| 204 | SGRY | Surgery Partners, Inc. | 3.46B | -0.26% | 2,607,716 | 3.36B |
| 205 | DYN | Dyne Therapeutics, Inc. | 3.37B | 0.39% | 1,909,757 | - |
| 206 | NHC | National HealthCare Corporation | 3.30B | 0.87% | 69,863 | 1.58B |
| 207 | TMDX | TransMedics Group, Inc. | 3.20B | 1.17% | 914,529 | 727.65M |
| 208 | TLX | Telix Pharmaceuticals Limited | 3.19B | 2.91% | 285,332 | 890.79M |
| 209 | ACAD | Acadia Pharmaceuticals Inc. | 3.17B | 0.49% | 2,395,206 | 1.20B |
| 210 | GRDN | Guardian Pharmacy Services, Inc. | 3.17B | 0.26% | 662,593 | 1.46B |
| 211 | IDYA | IDEAYA Biosciences, Inc. | 3.16B | 3.04% | 793,859 | 36.54M |
| 212 | DNLI | Denali Therapeutics Inc. | 3.16B | -0.60% | 873,556 | 21.38M |
| 213 | CELC | Celcuity Inc. | 3.16B | -4.07% | 696,791 | - |
| 214 | BHC | Bausch Health Companies Inc. | 3.13B | 0.72% | 2,401,051 | 11.11B |
| 215 | PRVA | Privia Health Group, Inc. | 3.07B | -1.35% | 821,208 | 2.43B |
| 216 | VCEL | Vericel Corporation | 3.03B | 0.71% | 808,229 | 324.17M |
| 217 | XERS | Xeris Biopharma Holdings, Inc. | 3.02B | 4.36% | 3,791,313 | 368.26M |
| 218 | XNCR | Xencor, Inc. | 3.00B | 1.47% | 1,103,234 | 200.49M |
| 219 | IRTC | iRhythm Holdings, Inc. | 2.98B | 3.04% | 1,088,532 | 854.04M |
| 220 | ZLAB | Zai Lab Limited | 2.97B | -0.04% | 920,192 | 441.73M |
| 221 | ATRC | AtriCure, Inc. | 2.93B | 2.26% | 660,703 | 589.80M |
| 222 | ADMA | ADMA Biologics, Inc. | 2.93B | 4.10% | 2,564,586 | 519.15M |
| 223 | MBX | MBX Biosciences, Inc. | 2.87B | 2.47% | 556,534 | - |
| 224 | AVAH | Aveanna Healthcare Holdings Inc. | 2.86B | -0.76% | 1,658,791 | 2.60B |
| 225 | RCUS | Arcus Biosciences, Inc. | 2.71B | 0.70% | 914,963 | 100.00M |
| 226 | PGNY | Progyny, Inc. | 2.69B | 0.19% | 892,245 | 1.34B |
| 227 | RGC | Regencell Bioscience Holdings Limited | 2.68B | 3.44% | 74,186 | - |
| 228 | CLOV | Clover Health Investments, Corp. | 2.66B | 0.81% | 4,070,221 | 2.74B |
| 229 | HCM | HUTCHMED (China) Limited | 2.59B | -1.95% | 32,023 | 549.12M |
| 230 | BEAM | Beam Therapeutics Inc. | 2.57B | 2.62% | 1,584,203 | 146.64M |
| 231 | ARDT | Ardent Health, Inc. | 2.56B | 1.45% | 609,330 | 6.45B |
| 232 | NEOG | Neogen Corporation | 2.53B | -0.60% | 2,959,207 | 884.00M |
| 233 | NAMS | NewAmsterdam Pharma Company N.V. | 2.48B | 8.03% | 2,622,677 | 25.94M |
| 234 | UFPT | UFP Technologies, Inc. | 2.43B | - | 52,595 | 649.52M |
| 235 | PHVS | Pharvaris N.V. | 2.40B | 0.56% | 421,682 | - |
| 236 | PVLA | Palvella Therapeutics, Inc. | 2.40B | -2.83% | 241,508 | - |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.40B | -0.54% | 931,886 | 1.96B |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.37B | -1.63% | 589,299 | 158.00K |
| 239 | SDGR | Schrödinger, Inc. | 2.37B | -2.75% | 2,150,473 | 269.20M |
| 240 | SEPN | Septerna, Inc. | 2.31B | -7.22% | 1,127,402 | 96.27M |
| 241 | PRGO | Perrigo Company plc | 2.30B | -1.66% | 1,295,827 | 4.09B |
| 242 | BHVN | Biohaven Ltd. | 2.29B | 0.53% | 1,597,585 | - |
| 243 | ADUS | Addus HomeCare Corporation | 2.29B | -0.63% | 201,107 | 1.50B |
| 244 | IMNM | Immunome, Inc. | 2.25B | 2.25% | 873,281 | 4.02M |
| 245 | VIR | Vir Biotechnology, Inc. | 2.25B | -0.15% | 1,288,482 | 302.80M |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.24B | 1.13% | 16,595,407 | 68.23M |
| 247 | BKD | Brookdale Senior Living Inc. | 2.21B | -1.71% | 15,090,773 | 2.86B |
| 248 | VERA | Vera Therapeutics, Inc. | 2.20B | 1.50% | 1,709,157 | 10.28M |
| 249 | ALMR | Alamar Biosciences, Inc. | 2.20B | 0.35% | 750,111 | 114.05M |
| 250 | NEO | NeoGenomics, Inc. | 2.18B | -0.77% | 957,333 | 787.75M |
| 251 | AUPH | Aurinia Pharmaceuticals Inc. | 2.17B | -0.55% | 1,591,112 | 321.74M |
| 252 | TRLV | Trulieve Cannabis Corp. | 2.17B | 1.26% | 1,165,582 | 1.08B |
| 253 | TRAX | First Tracks Biotherapeutics, Inc. | 2.12B | -3.44% | 487,072 | - |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.12B | -0.21% | 195,092 | 1.13B |
| 255 | TRVI | Trevi Therapeutics, Inc. | 2.11B | -0.64% | 1,517,274 | - |
| 256 | ESTA | Establishment Labs Holdings Inc. | 2.11B | 5.15% | 339,843 | 264.03M |
| 257 | PBH | Prestige Consumer Healthcare Inc. | 2.09B | -1.78% | 386,233 | 1.17B |
| 258 | REPL | Replimune Group, Inc. | 2.06B | -6.44% | 3,031,316 | - |
| 259 | AZTA | Azenta, Inc. | 2.04B | 20.80% | 2,488,630 | 621.70M |
| 260 | VCYT | Veracyte, Inc. | 2.03B | 4.36% | 3,345,075 | 581.78M |
| 261 | HRMY | Harmony Biosciences Holdings, Inc. | 2.01B | 2.00% | 971,350 | 989.36M |
| 262 | MAZE | Maze Therapeutics, Inc. | 2.01B | 3.61% | 484,131 | 20.00M |
| 263 | ZYME | Zymeworks Inc. | 2.01B | -7.60% | 897,858 | 265.97M |
| 264 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.00B | -2.04% | 2,036,769 | 213.00M |
| 265 | ETON | Eton Pharmaceuticals, Inc. | 1.97B | 1.27% | 1,133,407 | 141.06M |
| 266 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.97B | 1.59% | 2,641,904 | 961.51M |
| 267 | FTRE | Fortrea Holdings Inc. | 1.97B | -4.72% | 1,521,613 | 2.67B |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.96B | 3.34% | 844,736 | 140.84M |
| 269 | ZBIO | Zenas BioPharma, Inc. | 1.95B | 0.42% | 305,638 | 11.00M |
| 270 | XRAY | DENTSPLY SIRONA Inc. | 1.93B | 0.62% | 6,091,870 | 3.58B |
| 271 | AGL | agilon health, inc. | 1.93B | 1.14% | 163,509 | 6.00B |
| 272 | BFLY | Butterfly Network, Inc. | 1.91B | 9.68% | 6,481,686 | 123.26M |
| 273 | KMTS | Kestra Medical Technologies, Ltd. | 1.88B | 7.04% | 519,774 | 106.73M |
| 274 | KLRA | Kailera Therapeutics, Inc. | 1.87B | 0.98% | 610,026 | - |
| 275 | COAG | Hemab Therapeutics Holdings, Inc. | 1.84B | 1.44% | 655,780 | - |
| 276 | STOK | Stoke Therapeutics, Inc. | 1.82B | 2.02% | 834,933 | 28.21M |
| 277 | LMAT | LeMaitre Vascular, Inc. | 1.81B | 0.34% | 137,327 | 269.36M |
| 278 | LYCA | Lycia Therapeutics, Inc. | 1.81B | 0.45% | 329,587 | 4.44M |
| 279 | INSP | Inspire Medical Systems, Inc. | 1.80B | -0.32% | 617,113 | 880.94M |
| 280 | CERT | Certara, Inc. | 1.79B | -3.30% | 3,155,069 | 425.76M |
| 281 | SRPT | Sarepta Therapeutics, Inc. | 1.79B | 1.58% | 2,053,276 | 1.96B |
| 282 | NRIX | Nurix Therapeutics, Inc. | 1.78B | 2.83% | 2,979,929 | 701.94M |
| 283 | ALVO | Alvotech | 1.76B | 0.82% | 840,018 | 492.31M |
| 284 | MESO | Mesoblast Limited | 1.74B | -2.43% | 208,384 | 120.25M |
| 285 | ABSI | Absci Corporation | 1.74B | 1.50% | 5,381,368 | 1.56M |
| 286 | GENB | Generate Biomedicines, Inc. | 1.73B | -2.10% | 455,690 | 26.48M |
| 287 | PSNL | Personalis, Inc. | 1.73B | 0.50% | 1,138,958 | 80.77M |
| 288 | QURE | uniQure N.V. | 1.72B | 8.26% | 2,467,432 | 20.17M |
| 289 | BRVE | Braveheart Bio, Inc. | 1.71B | 6.52% | 488,966 | - |
| 290 | SLS | SELLAS Life Sciences Group, Inc. | 1.70B | 0.60% | 3,889,937 | - |
| 291 | HCSG | Healthcare Services Group, Inc. | 1.70B | -0.36% | 390,798 | 1.88B |
| 292 | RARE | Ultragenyx Pharmaceutical Inc. | 1.70B | 3.47% | 2,674,355 | 730.00M |
| 293 | PGEN | Precigen, Inc. | 1.69B | 4.42% | 4,611,942 | 156.94M |
| 294 | ASTH | Astrana Health, Inc. | 1.69B | 2.36% | 285,379 | 3.91B |
| 295 | WGS | GeneDx Holdings Corp. | 1.65B | 0.53% | 1,093,226 | 460.78M |
| 296 | ENOV | Enovis Corporation | 1.65B | 1.17% | 1,085,031 | 2.31B |
| 297 | NVAX | Novavax, Inc. | 1.65B | -2.16% | 5,895,960 | 411.65M |
| 298 | SNDA | Sonida Senior Living, Inc. | 1.65B | 0.65% | 326,341 | 593.56M |
| 299 | NBTX | Nanobiotix S.A. | 1.64B | 0.24% | 63,895 | 13.15M |
| 300 | OMCL | Omnicell, Inc. | 1.64B | -0.92% | 418,421 | 1.24B |
| 301 | IMCR | Immunocore Holdings plc | 1.64B | -2.25% | 368,135 | 429.30M |
| 302 | TDOC | Teladoc Health, Inc. | 1.63B | - | 3,476,344 | 2.47B |
| 303 | ALHC | Alignment Healthcare, Inc. | 1.61B | 0.26% | 3,285,990 | 4.94B |
| 304 | RAPP | Rapport Therapeutics, Inc. | 1.60B | 4.08% | 631,810 | 20.00M |
| 305 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 2.15% | 3,035,354 | 52.89M |
| 306 | LMRI | Lumexa Imaging Holdings, Inc. | 1.53B | 14.58% | 907,881 | 1.06B |
| 307 | NUVB | Nuvation Bio Inc. | 1.51B | 2.14% | 2,951,998 | 201.73M |
| 308 | CNMD | CONMED Corporation | 1.51B | -0.86% | 204,861 | 1.37B |
| 309 | ANIP | ANI Pharmaceuticals, Inc. | 1.51B | -0.22% | 1,011,691 | 1.04B |
| 310 | USPH | U.S. Physical Therapy, Inc. | 1.49B | 0.87% | 166,132 | 829.86M |
| 311 | GPCR | Structure Therapeutics Inc. | 1.49B | -3.59% | 1,002,761 | - |
| 312 | ADRX | ADARx Pharmaceuticals, Inc. | 1.49B | -1.99% | 509,927 | 6.13M |
| 313 | KARD | Kardigan, Inc. | 1.47B | 3.29% | 432,159 | - |
| 314 | OCUL | Ocular Therapeutix, Inc. | 1.47B | 0.76% | 2,989,837 | 50.38M |
| 315 | PCRX | Pacira BioSciences, Inc. | 1.46B | -0.08% | 944,872 | 743.30M |
| 316 | AMN | AMN Healthcare Services, Inc. | 1.46B | 0.24% | 491,222 | 3.52B |
| 317 | ANAB | AnaptysBio, Inc. | 1.46B | 0.81% | 230,346 | 106.09M |
| 318 | KRSA | Korsana Biosciences, Inc. | 1.45B | 2.35% | 167,277 | - |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.45B | -0.14% | 532,136 | - |
| 320 | LBRX | LB Pharmaceuticals Inc | 1.45B | -0.51% | 341,759 | - |
| 321 | DMRA | Damora Therapeutics, Inc. | 1.44B | -3.73% | 535,808 | - |
| 322 | MLYS | Mineralys Therapeutics, Inc. | 1.43B | 4.12% | 1,886,909 | - |
| 323 | PAHC | Phibro Animal Health Corporation | 1.43B | 1.47% | 145,577 | 1.54B |
| 324 | NVCR | NovoCure Limited | 1.40B | 1.52% | 1,533,011 | 725.39M |
| 325 | AVLN | Avalyn Pharma Inc. | 1.40B | 1.44% | 474,404 | - |
| 326 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | 0.12% | 2,114,566 | 5.49M |
| 327 | AAPG | Ascentage Pharma Group International | 1.37B | -3.23% | 7,312 | 94.61M |
| 328 | MNKD | MannKind Corporation | 1.35B | -0.95% | 3,283,019 | 413.37M |
| 329 | SVRA | Savara Inc. | 1.34B | 1.42% | 9,257,625 | - |
| 330 | PRCT | PROCEPT BioRobotics Corporation | 1.34B | 1.26% | 970,402 | 352.31M |
| 331 | INVA | Innoviva, Inc. | 1.34B | -1.15% | 650,124 | 438.32M |
| 332 | STAA | STAAR Surgical Company | 1.34B | 11.81% | 938,937 | 328.27M |
| 333 | INBX | Inhibrx Biosciences, Inc. | 1.33B | -0.02% | 165,738 | 1.30M |
| 334 | GHRS | GH Research PLC | 1.32B | -1.58% | 128,387 | - |
| 335 | CMPS | COMPASS Pathways plc | 1.32B | 0.54% | 2,624,241 | - |
| 336 | OMER | Omeros Corporation | 1.31B | 4.91% | 756,928 | 38.42M |
| 337 | NKTR | Nektar Therapeutics | 1.31B | 1.75% | 525,070 | 54.59M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | 0.32% | 2,553,846 | 1.08B |
| 339 | NUTX | Nutex Health Inc. | 1.30B | 1.58% | 98,627 | 796.53M |
| 340 | INNV | InnovAge Holding Corp. | 1.30B | 1.39% | 385,520 | 1.02B |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.29B | 2.34% | 833,699 | - |
| 342 | PNTG | The Pennant Group, Inc. | 1.29B | 0.16% | 304,145 | 1.17B |
| 343 | URGN | UroGen Pharma Ltd. | 1.28B | 3.08% | 818,221 | 250.25M |
| 344 | OPK | OPKO Health, Inc. | 1.27B | - | 2,648,563 | 654.10M |
| 345 | CRON | Cronos Group Inc. | 1.27B | 1.17% | 1,072,952 | 206.20M |
| 346 | ANRO | Alto Neuroscience, Inc. | 1.25B | 8.88% | 1,221,964 | - |
| 347 | GDRX | GoodRx Holdings, Inc. | 1.25B | 3.11% | 894,070 | 785.23M |
| 348 | FRNM | Freenome, Inc. | 1.24B | 7.34% | 1,074,795 | 217.86M |
| 349 | VOR | Vor Biopharma Inc. | 1.23B | 2.71% | 407,305 | - |
| 350 | SLN | Silence Therapeutics plc | 1.23B | -0.10% | 294,496 | 615.00K |
| 351 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.22B | -1.58% | 497,658 | 745.79M |
| 352 | SGP | SpyGlass Pharma, Inc. | 1.17B | 2.31% | 77,564 | - |
| 353 | AHG | Akso Health Group | 1.16B | 8.09% | 13,512 | 13.83M |
| 354 | MLTX | MoonLake Immunotherapeutics | 1.15B | 7.56% | 1,943,455 | - |
| 355 | IART | Integra LifeSciences Holdings Corporation | 1.15B | 1.65% | 1,000,166 | 1.66B |
| 356 | VSTM | Verastem, Inc. | 1.15B | 4.12% | 2,552,777 | 100.30M |
| 357 | SPTX | Seaport Therapeutics, Inc. | 1.14B | -3.00% | 225,685 | - |
| 358 | ATEC | Alphatec Holdings, Inc. | 1.14B | 5.00% | 5,823,834 | 839.72M |
| 359 | SIBN | SI-BONE, Inc. | 1.13B | -0.64% | 547,414 | 220.65M |
| 360 | IRMD | IRADIMED CORPORATION | 1.11B | -0.16% | 79,774 | 89.34M |
| 361 | HROW | Harrow, Inc. | 1.10B | -3.26% | 979,205 | 303.25M |
| 362 | CBLL | CeriBell, Inc. | 1.08B | 1.16% | 232,702 | 108.72M |
| 363 | GMRS | GMR Solutions Inc. | 1.06B | 7.01% | 2,553,801 | 5.97B |
| 364 | JBIO | Jade Biosciences, Inc. | 1.05B | 0.85% | 678,937 | - |
| 365 | CSTL | Castle Biosciences, Inc. | 1.05B | -1.25% | 335,264 | 377.13M |
| 366 | AHCO | AdaptHealth Corp. | 1.04B | 1.04% | 2,239,957 | 3.44B |
| 367 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | 4.95% | 245,072 | 99.00K |
| 368 | AORT | Artivion, Inc. | 980.67M | -1.81% | 646,248 | 481.88M |
| 369 | BBNX | Beta Bionics, Inc. | 968.28M | 7.81% | 913,854 | 127.27M |
| 370 | CRVS | Corvus Pharmaceuticals, Inc. | 967.53M | 0.88% | 822,126 | - |
| 371 | AKTS | Aktis Oncology, Inc. | 947.76M | -2.35% | 173,880 | 10.06M |
| 372 | OMDA | Omada Health, Inc. | 945.45M | 1.20% | 1,210,233 | 333.04M |
| 373 | ORIC | ORIC Pharmaceuticals, Inc. | 932.87M | 1.01% | 773,258 | - |
| 374 | PHAR | Pharming Group N.V. | 930.57M | 1.36% | 12,712 | 386.75M |
| 375 | MGTX | MeiraGTx Holdings plc | 929.70M | 0.62% | 455,889 | 397.50M |
| 376 | BVS | Bioventus Inc. | 926.03M | -1.70% | 463,279 | 585.64M |
| 377 | IVA | Inventiva S.A. | 918.85M | 1.52% | 2,371,995 | 2.81M |
| 378 | IMTX | Immatics N.V. | 914.46M | 4.21% | 964,315 | 49.33M |
| 379 | LTGO | Latigo Biotherapeutics, Inc. | 896.37M | 1.43% | 198,821 | - |
| 380 | HSTM | HealthStream, Inc. | 884.68M | 0.59% | 314,891 | 327.95M |
| 381 | GLUE | Monte Rosa Therapeutics, Inc. | 880.99M | -1.81% | 1,260,541 | 70.33M |
| 382 | KIDS | OrthoPediatrics Corp. | 879.14M | 0.57% | 167,877 | 264.14M |
| 383 | BBTX | Bambusa Therapeutics, Inc. | 874.17M | 0.65% | 157,171 | - |
| 384 | SNDX | Syndax Pharmaceuticals, Inc. | 863.37M | 1.05% | 4,355,557 | 289.68M |
| 385 | ALMS | Alumis Inc. | 856.86M | 3.44% | 1,283,191 | 7.40M |
| 386 | SLDB | Solid Biosciences Inc. | 848.24M | 6.00% | 1,957,866 | - |
| 387 | CTY | City Therapeutics, Inc. | 846.36M | -13.30% | 458,676 | 14.34M |
| 388 | RIGL | Rigel Pharmaceuticals, Inc. | 838.31M | 1.39% | 140,655 | 288.21M |
| 389 | LXRX | Lexicon Pharmaceuticals, Inc. | 832.59M | 0.54% | 3,086,427 | 38.54M |
| 390 | QDEL | QuidelOrtho Corporation | 817.18M | 3.39% | 1,512,861 | 2.59B |
| 391 | SGMT | Sagimet Biosciences Inc. | 809.07M | 4.78% | 1,790,259 | - |
| 392 | IRWD | Ironwood Pharmaceuticals, Inc. | 806.23M | 1.25% | 2,820,994 | 400.30M |
| 393 | ANNX | Annexon, Inc. | 799.30M | -0.48% | 3,080,099 | - |
| 394 | OBX | Obsidian Therapeutics, Inc. | 795.63M | -6.26% | 663,422 | - |
| 395 | PHR | Phreesia, Inc. | 795.13M | -2.44% | 776,806 | 507.79M |
| 396 | AURA | Aura Biosciences, Inc. | 792.01M | -0.52% | 648,447 | - |
| 397 | INMD | InMode Ltd. | 789.21M | 3.47% | 984,035 | 373.60M |
| 398 | ARDX | Ardelyx, Inc. | 786.80M | 3.99% | 3,293,805 | 468.22M |
| 399 | VREX | Varex Imaging Corporation | 775.10M | -0.33% | 406,690 | 865.00M |
| 400 | COLL | Collegium Pharmaceutical, Inc. | 770.98M | 1.39% | 500,401 | 815.19M |
| 401 | PRME | Prime Medicine, Inc. | 764.99M | 10.26% | 12,846,789 | 4.07M |
| 402 | ATTO | Attovia Therapeutics, Inc. | 763.75M | 0.54% | 150,110 | 1.44M |
| 403 | JANX | Janux Therapeutics, Inc. | 758.06M | 2.91% | 1,189,478 | 23.29M |
| 404 | DCTH | Delcath Systems, Inc. | 757.34M | 8.31% | 2,017,276 | 109.96M |
| 405 | CTKB | Cytek Biosciences, Inc. | 753.32M | -0.52% | 667,046 | 207.65M |
| 406 | DBVT | DBV Technologies S.A. | 743.94M | 3.21% | 373,312 | 3.74M |
| 407 | OABI | OmniAb, Inc. | 743.89M | - | 789,284 | 40.21M |
| 408 | CGEM | Cullinan Therapeutics, Inc. | 736.85M | 1.07% | 985,752 | - |
| 409 | IAM | Iambic Therapeutics, Inc. | 729.26M | 4.09% | 364,596 | 18.25M |
| 410 | NVCT | Nuvectis Pharma, Inc. | 722.17M | -0.38% | 153,122 | - |
| 411 | CLYM | Climb Bio, Inc. | 719.54M | 4.34% | 1,664,486 | - |
| 412 | FLGT | Fulgent Genetics, Inc. | 718.03M | -0.31% | 494,575 | 330.28M |
| 413 | IMMX | Immix Biopharma, Inc. | 717.94M | 3.71% | 1,057,095 | - |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 717.62M | 4.25% | 837,177 | 92.01M |
| 415 | KURA | Kura Oncology, Inc. | 710.22M | 2.11% | 3,653,253 | 79.31M |
| 416 | CADL | Candel Therapeutics, Inc. | 705.50M | -1.39% | 1,096,934 | - |
| 417 | ZVRA | Zevra Therapeutics, Inc. | 705.13M | -0.59% | 743,309 | 147.76M |
| 418 | OLMA | Olema Pharmaceuticals, Inc. | 704.35M | 10.59% | 1,819,914 | - |
| 419 | BCAX | Bicara Therapeutics Inc. | 699.06M | 3.44% | 1,506,163 | - |
| 420 | ANL | Adlai Nortye Group Ltd. | 698.72M | 8.94% | 195,931 | 18.06M |
| 421 | APMD | Apnimed, Inc. | 698.56M | 5.80% | 195,574 | 115.12M |
| 422 | AVBP | ArriVent BioPharma, Inc. | 698.52M | 0.11% | 911,024 | 5.00M |
| 423 | DSGN | Design Therapeutics, Inc. | 689.67M | 1.13% | 455,701 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 688.38M | 4.58% | 1,981,058 | 6.40M |
| 425 | SANA | Sana Biotechnology, Inc. | 686.16M | -5.76% | 2,727,844 | - |
| 426 | HELP | Helus Pharma Inc. | 686.04M | 3.53% | 1,363,404 | - |
| 427 | WVE | Wave Life Sciences, Inc. | 674.52M | 0.29% | 1,703,625 | 70.92M |
| 428 | DNA | Ginkgo Bioworks Holdings, Inc. | 664.38M | -14.65% | 2,775,972 | 130.75M |
| 429 | GERN | Geron Corporation | 657.12M | 4.70% | 6,557,579 | 217.52M |
| 430 | PACB | Pacific Biosciences of California, Inc. | 654.02M | -6.70% | 10,693,819 | 161.39M |
| 431 | CAPR | Capricor Therapeutics, Inc. | 652.35M | 26.49% | 10,070,073 | 11.13M |
| 432 | SOPH | SOPHiA GENETICS SA | 639.44M | -5.03% | 837,911 | 90.97M |
| 433 | CBIO | Crescent Biopharma, Inc. | 631.53M | 6.00% | 269,517 | 11.88M |
| 434 | EVO | Evotec SE | 623.20M | - | 61,660 | 815.72M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 607.75M | 1.92% | 165,790 | 356.42M |
| 436 | SRZN | Surrozen, Inc. | 607.69M | -2.33% | 156,970 | 10.53M |
| 437 | SGHT | Sight Sciences, Inc. | 606.92M | 1.58% | 249,735 | 88.40M |
| 438 | AVR | Anteris Technologies Global Corp. | 604.46M | 5.26% | 751,543 | 2.33M |
| 439 | ABUS | Arbutus Biopharma Corporation | 594.78M | 1.57% | 2,129,447 | 181.49M |
| 440 | ETRA | Electra Therapeutics, Inc. | 593.15M | 18.27% | 384,954 | - |
| 441 | SENS | Senseonics Holdings, Inc. | 570.81M | 3.89% | 1,378,931 | 60.01M |
| 442 | NRC | NRC Health | 570.01M | 0.04% | 125,983 | 143.79M |
| 443 | VALN | Valneva SE | 565.09M | 0.85% | 49,985 | 163.30M |
| 444 | EVH | Evolent Health, Inc. | 564.40M | 3.96% | 2,204,724 | 2.34B |
| 445 | ENTX | Entera Bio Ltd. | 560.72M | -0.62% | 103,427 | 42.00K |
| 446 | RGNX | REGENXBIO Inc. | 560.06M | 10.14% | 1,845,174 | 153.91M |
| 447 | MYGN | Myriad Genetics, Inc. | 548.67M | 0.88% | 1,379,269 | 803.60M |
| 448 | TKNO | Alpha Teknova, Inc. | 542.22M | -1.26% | 390,301 | 45.95M |
| 449 | SRTA | Strata Critical Medical, Inc. | 536.81M | -0.17% | 1,112,743 | 280.76M |
| 450 | RCEL | AVITA Medical, Inc. | 535.03M | -1.98% | 674,543 | 84.68M |
| 451 | EPRX | Eupraxia Pharmaceuticals Inc. | 529.88M | 5.64% | 615,849 | - |
| 452 | OVID | Ovid Therapeutics Inc. | 524.67M | -0.71% | 1,823,059 | 1.45M |
| 453 | ANGO | AngioDynamics, Inc. | 522.32M | 2.90% | 441,400 | 325.38M |
| 454 | DMAC | DiaMedica Therapeutics Inc. | 520.92M | -0.10% | 139,358 | - |
| 455 | NGNE | Neurogene Inc. | 519.59M | -0.71% | 199,761 | 925.00K |
| 456 | STTK | Shattuck Labs, Inc. | 514.30M | 4.12% | 983,939 | 1.00M |
| 457 | BLSM | BlossomHill Therapeutics, Inc. | 512.37M | 13.20% | 203,683 | - |
| 458 | CARL | Carlsmed, Inc. | 509.72M | 26.44% | 611,063 | 71.78M |
| 459 | PHAT | Phathom Pharmaceuticals, Inc. | 498.82M | 15.23% | 1,572,800 | 274.88M |
| 460 | INDP | Indaptus Therapeutics, Inc. | 493.00M | 10.69% | 264,980 | - |
| 461 | AVTX | Avalo Therapeutics, Inc. | 492.07M | 18.85% | 1,839,393 | 59.00K |
| 462 | EOLS | Evolus, Inc. | 491.12M | 8.96% | 1,286,920 | 325.47M |
| 463 | MDXG | MiMedx Group, Inc. | 484.47M | -1.48% | 1,225,252 | 303.73M |
| 464 | CTEV | Claritev Corporation | 481.68M | -1.60% | 437,980 | 1.02B |
| 465 | MNPR | Monopar Therapeutics Inc. | 481.46M | -0.07% | 157,459 | - |
| 466 | OBIO | Orchestra BioMed Holdings, Inc. | 473.02M | 4.89% | 452,902 | 31.21M |
| 467 | RLMD | Relmada Therapeutics, Inc. | 472.55M | 3.75% | 1,504,313 | - |
| 468 | OCS | Oculis Holding AG | 469.78M | 0.26% | 227,358 | 1.12M |
| 469 | GYRE | Gyre Therapeutics, Inc. | 466.26M | 0.71% | 130,505 | 110.06M |
| 470 | CTMX | CytomX Therapeutics, Inc. | 464.35M | 7.58% | 4,992,591 | 14.03M |
| 471 | KMDA | Kamada Ltd. | 463.12M | 0.37% | 120,693 | 196.87M |
| 472 | SI | Shoulder Innovations, Inc. | 458.62M | -0.05% | 191,037 | 64.49M |
| 473 | ASMB | Assembly Biosciences, Inc. | 455.47M | 4.78% | 203,140 | 74.85M |
| 474 | ARVN | Arvinas, Inc. | 452.50M | -0.14% | 730,098 | 275.30M |
| 475 | AQST | Aquestive Therapeutics, Inc. | 449.96M | 1.70% | 2,179,689 | 48.84M |
| 476 | MOBI | Mobia Medical, Inc. | 448.93M | 10.41% | 274,591 | 51.89M |
| 477 | PRTA | Prothena Corporation plc | 448.28M | 1.99% | 392,331 | 52.74M |
| 478 | BWAY | BrainsWay Ltd. | 437.16M | 5.34% | 153,259 | 60.70M |
| 479 | YDES | YD Bio Limited | 435.61M | 1.99% | 13,249 | 1.24M |
| 480 | NPCE | NeuroPace, Inc. | 429.74M | -1.34% | 89,281 | 106.99M |
| 481 | TECX | Tectonic Therapeutic, Inc. | 429.30M | -0.05% | 133,473 | - |
| 482 | STLN | Starling Oncology, Inc. | 428.36M | -3.23% | 2,974,306 | 620.45M |
| 483 | CERS | Cerus Corporation | 428.14M | 8.72% | 2,237,628 | 226.57M |
| 484 | RZLT | Rezolute, Inc. | 426.96M | 1.24% | 974,182 | - |
| 485 | CTNM | Contineum Therapeutics, Inc. | 422.89M | 1.99% | 287,645 | - |
| 486 | MASS | 908 Devices Inc. | 418.32M | 0.70% | 537,588 | 65.79M |
| 487 | PBYI | Puma Biotechnology, Inc. | 417.72M | -0.74% | 397,807 | 231.83M |
| 488 | IRD | Opus Genetics, Inc. | 416.58M | 1.89% | 1,206,811 | 7.91M |
| 489 | MPLT | MapLight Therapeutics, Inc. | 415.71M | 0.54% | 291,886 | - |
| 490 | LYEL | Lyell Immunopharma, Inc. | 414.51M | 0.66% | 153,668 | 15.00K |
| 491 | CRMD | CorMedix Inc. | 413.10M | -1.30% | 1,625,941 | 462.25M |
| 492 | SLBT | SL Science Holding Limited | 411.96M | -19.64% | 319,359 | 3.27M |
| 493 | ASPE | Aspen Neuroscience, Inc. | 401.87M | 7.88% | 290,415 | - |
| 494 | SPRY | ARS Pharmaceuticals, Inc. | 397.09M | 10.64% | 3,845,862 | 122.14M |
| 495 | ALEC | Alector, Inc. | 391.55M | 3.95% | 3,475,916 | 173.47M |
| 496 | PRLD | Prelude Therapeutics Incorporated | 389.32M | 0.53% | 295,281 | 22.42M |
| 497 | ZJYL | Jin Medical International Ltd. | 385.10M | 16.63% | 227,538 | 19.73M |
| 498 | TRXB | TRex Bio, Inc. | 383.64M | 8.53% | 107,852 | - |
| 499 | TLRY | Tilray Brands, Inc. | 382.79M | -1.51% | 6,535,067 | 963.10M |
| 500 | CCCC | C4 Therapeutics, Inc. | 379.51M | -3.67% | 2,133,047 | 32.28M |